Key result
Estrogens protect against metabolic disease by promoting subcutaneous fat storage and modulating lipolysis.
Why the study?
Sex differences in regulation of adipose tissue and their impact on metabolic disease resistance require comprehensive review.
Answers are grounded in this paper and cite their sources.
This review highlights that estrogen-driven accumulation of subcutaneous adipose tissue in women confers a protective metabolic profile compared to visceral fat.
This review is focused on sex differences in regulation of adipose tissue. The heterogeneity of structural and functional features as well as differences in regulation of visceral and subcutaneous adipose tissues are discussed. It was shown that estrogens have pleiotropic protective impact by direct influence on adipocytes and indirect effect through hypothalamic regulation of sympathetic innervation of adipose tissue, modulating lipolysis, proliferation of preadipocytes and hyperplasia, as well as transformation of white adipocytes to brown ones. The high volume of subcutaneous adipose tissue in women is determined by the effects of estrogens and is the main factor that provides female special resistance to metabolic diseases. In general, an increase of subcutaneous fat is more favorable for metabolic profile. In contrast, visceral fat depot is associated with insulin resistance and the development of associated pathology.
No takes yet. Share an insight, caveat, or question.
Sulaieva et al. (2017) conducted a review in Adipose tissue regulation and metabolic diseases. Sex differences and estrogens vs. Males / low estrogen states was evaluated. Estrogens exert a pleiotropic protective effect by promoting subcutaneous fat accumulation and modulating lipolysis, determining female resistance to metabolic diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: